Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder

NCT03787628 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT03787628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03787628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol Effects on Craving and Relapse Prevention in Opioid Use Disorder
Lead sponsor
University of California, Los Angeles
Phase
Phase 2
Overall status
Completed
Start date
May 19, 2022
Completion date
March 12, 2024
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid-use disorder